Linking Matrix Rigidity with EMT and Cancer Invasion.

[1]  Albert C. Chen,et al.  Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex. , 2020, Developmental cell.

[2]  S. Turunen,et al.  Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer , 2020, EMBO molecular medicine.

[3]  V. Weaver,et al.  Tissue mechanics, an important regulator of development and disease , 2019, Philosophical Transactions of the Royal Society B.

[4]  V. Weaver,et al.  The Extracellular Matrix Modulates the Metastatic Journey. , 2019, Developmental cell.

[5]  Y. Maru,et al.  Roles of EphA1/A2 and ephrin‐A1 in cancer , 2019, Cancer science.

[6]  R. Treisman,et al.  Mutual dependence of the MRTF–SRF and YAP–TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics , 2017, Genes & development.

[7]  Albert C. Chen,et al.  Matrix stiffness drives Epithelial-Mesenchymal Transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway , 2015, Nature Cell Biology.

[8]  Kristen M. Naegle,et al.  Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants , 2013, The Biochemical journal.

[9]  E. Ingley.  Functions of the Lyn tyrosine kinase in health and disease , 2012, Cell Communication and Signaling.

[10]  M. Kinch,et al.  EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells. , 2004, Molecular cancer research : MCR.